Bill > S04587

This bill modifies prescription labeling requirements for mifepristone and misoprostol, two medications commonly used in medical abortion and miscarriage management. The bill allows prescription labels to include the name or address of the dispensing healthcare practice instead of the individual dispenser's name, and permits prescribers to request that their healthcare practice's name or address be used on the label instead of their personal name. Additionally, the bill mandates that healthcare prescribers must inform patients when they choose to use their practice's name or address on the prescription label rather than their individual name when prescribing these medications. These changes provide healthcare providers with more flexibility in labeling while ensuring patient transparency about the source of their prescription. The bill is part of a broader set of legislative changes related to medication labeling and appears to be specifically focused on protecting the privacy and potentially the safety of healthcare providers who prescribe these specific medications.

https://www.nysenate.gov/legislation/bills/2025/S4587